verrucarol

Known as: (4 beta)-12,13-epoxytrichothec-9-ene-4,15-diol 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1973-2018
02419732018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
There are few studies on rhinitis and sick building syndrome (SBS) among students in tropical countries. We studied associations… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2005
2005
Highly respirable particles (diameter, <1 microm) constitute the majority of particulate matter found in indoor air. It is… (More)
  • figure 1
  • figure 2
  • table 2
  • table 1
  • figure 3
Is this relevant?
1994
1994
The pharmacokinetics and renal excretion of a trichothecene mycotoxin, verrucarol, were studied in six mongrel dogs following IV… (More)
Is this relevant?
1993
1993
Chinese hamster ovary cells were used to examine the effect of emetine upon the toxicity of T-2 toxin and several related… (More)
  • figure 2
  • table 1
  • table 2
  • figure 4
  • figure 5
Is this relevant?
1990
1990
Verrucarol is a simple trichothecene which is structurally related to T-2 and HT-2 toxins. Several macrocyclic trichothecenes… (More)
Is this relevant?
1988
1988
The effect of in vitro exposure to the macrocyclic trichothecenes roridin A and verrucarin A on human lymphocyte transformation… (More)
Is this relevant?
1986
1986
Nineteen 12,13-epoxytrichothecene mycotoxins were tested for their relative capabilities to inhibit protein synthesis in Vero… (More)
Is this relevant?
1984
1984
Verrucarol was obtained from a simple procedure that involved the hydrolysis of a crude extract of a culture of Myrothecium… (More)
Is this relevant?
1984
1984
Immunization of rabbits with deoxyverrucarol (DOVE) conjugated to bovine serum albumin resulted in antibodies bound with either… (More)
Is this relevant?
1984
1984
4-Deoxyverrucarol (4) has been synthesized for use in studies for the preparation and development of monoclonal antibodies for… (More)
Is this relevant?